Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 9 of 9« First...56789

Siri speaks: The human behind the voice of Siri – and how marketers can benefit from voice recognition technology

We usually see Siri spelled in caps and lower case, as if she’s a real person with a very weird name, instead of an application on your phone. But SIRI is in fact an acronym for Speech Interpretation and Recognition Interface. If you require a more intimate relationship with the voice on your phone, take comfort that Siri also means “beautiful woman who leads you to victory” in Norwegian.

Read More »

Disruption, explained: The theory and practice of overturning marketing conventions

We all follow conventions. Coffee in the morning, ties on men, noun before verb (usually), ladies order first, pass on the left, no white after Labor Day. For better or worse, conventions form an invisible web around our actions and the way we think, even if we have no idea how those conventions began or what their original purpose or meaning was. We are so used to most of the conventions that guide our lives that we don’t actively think about them at all.

Read More »

Twitter’s new character limit means more freedom for pharma marketers

After years of tests and speculation about new character limits on Twitter, the platform formally announced that the famous 140-character limit is no more. Now, tweets can include up to 280 characters, doubling

Read More »

GSK names new chief scientific officer and R&D president

GlaxoSmithKline plc named Hal Barron, M.D., as chief scientific officer and president of R&D.

Read More »

Inception Companies hires Matt Giegerich as CEO for two lead businesses

The Inception Companies appointed Matt Giegerich, longtime CEO of WPP’s Ogilvy CommonHealth, to serve as CEO for Inception’s two largest business units.

Read More »

New senior VP and VP for Bayer Consumer Health

Brenda L. Raphael was appointed senior VP and general manager of Bayer’s Therapeutics Business Unit of Consumer Health Commercial Operations North America. Jennifer Brendel was named VP of communications for Bayer’s Consumer Health Division in the United States.

Read More »

Astellas promotes two into informatics, medical affairs roles

Astellas promoted two executives into new roles. Nate Crisel is now VP, Real World Informatics & Analytics (RWI), at Astellas, reporting to Chikashi Takeda, chief financial officer. Gary Thal, M.D., was promoted to VP, Specialty, Medical Affairs, Americas, reporting to Shontelle Dodson, PharmD., senior VP, Medical Affairs, Americas.

Read More »

EMD Serono picks market access senior VP

Robert Truckenmiller was tapped as senior VP, Market Access & Customer Solution

Read More »

People On The Move: Specialty Pharma Companies

Karen Reeves, M.D., was appointed by AZTherapies as president and chief medical officer.

Read More »

People On The Move: Biotechnology Companies

Diego Miralles, M.D., was named CEO of Vividion Therapeutics Inc.

Read More »

People On The Move: Service Companies

Dominique P. Monnet was appointed to the position of president of PDL BioPharma Inc.

Read More »

One Drop to integrate Fitbit data into diabetes app

One Drop, a digital diabetes care and self-management platform, announced a multi-part collaboration with Fitbit that will use the power of Fitbit wearable data to bring enhanced data-driven care management tools to the diabetes community.

Read More »

Takeda, Lundbeck study app for depression

Takeda Pharmaceuticals U.S.A. Inc., Lundbeck U.S., and Advocate Health Care announced a collaboration focusing on the use of digital technology to support people living with depression.

Read More »

Interactive & Digital Marketing: Facts and Figures

A DRG Digital – Manhattan Research study of 189 U.S. P&T committee members making formulary decisions at hospitals, IDNs, PBMs, MCOs and ACOs found that on average, these key professionals spend upwards of three hours per day using digital resources to inform their committee work.

Read More »

Health Outcomes: Facts & Figures

Nearly 3 in 10 – 29 percent – of total U.S. health care payments were tied to alternative payment models in 2016, compared to 23 percent in 2015, according to a report by the Health Care Payment Learning & Action Network. The public-private partnership was launched in March 2015 to drive adoption and alignment of APMs.

Read More »

Diane Iler-Smith Joins Biolumina as SVP, Executive Creative Director

Diane Iler-Smith has returned to Biolumina as SVP, Executive Creative Director. Biolumina is a full-service, integrated agency delivering omnichannel solutions for the pharmaceutical industry

Read More »

FDA approves Mylan’s biosimilar of Roche’s cancer drug Herceptin

The U.S. Food and Drug Administration approved Mylan NV’s biosimilar version of Roche’s blockbuster breast cancer treatment Herceptin.

Read More »

Bristol-Myers’ Lung Cancer Opdivo Trial Stopped Early for Superior Overall Survival

Bristol-Myers Squibb announced that the company’s Phase III trial pitting Opdivo against chemotherapy drug docetaxel in treating certain lung cancer patients was stopped early after meeting key endpoints.

Read More »

Indivior drug to fight opioid addiction approved by U.S. FDA

Indivior’s experimental drug to help fight America’s growing opioid addiction crisis was approved by the U.S. Food and Drug Administration, boosting the company’s sales prospects as competitors threaten revenues from an older product.

Read More »

Page 9 of 9« First...56789

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom